Ani Pharmaceuticals Inc (ANIP) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Ani Pharmaceuticals Inc  (NASDAQ: ANIP)
 

Ani Pharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Ani Pharmaceuticals Inc inventory turnover ratio, the Ani Pharmaceuticals Inc's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 2.69 in the second quarter 2026, ANIP's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Ani Pharmaceuticals Inc in Jun 30 2026 quarter, has decreased to 136 days, compare to 144 days, in the Mar 31 2026 quarter.

Within Healthcare sector 149 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 1378, from total ranking in the first quarter 2026 at 1608.

ANIP Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Ani Pharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ANIP Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 3.49 % 4.41 % 4.59 % -1.06 % 10.26 %
Y / Y Cost of Sales Growth 34.23 % 28.13 % 24.9 % 48.06 % 29.32 %
Inventory Turnover Ratio (TTM) 2.69 2.53 2.42 2.3 2.08
ANIP's Total Ranking # 1378 # 1608 # 1480 # 1566 # 1586
Average inventory processing period 136 144 151 159 176
Seq. Inventory Growth -0.22 % 0.28 % -2.33 % 5.9 % 0.66 %
Seq. Cost of Sales Growth 7.03 % -6.67 % 7.37 % 25.16 % 2.16 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 37
Healthcare Sector # 150
Overall Market # 1378

Inventory Turnover Ratio Statistics
High Average Low
3.6 1.77 0.99
(Mar 31 2014)   (Mar 31 2016)



ANIP Company Profile >> Back to ANIP Efficiency Comparisons >> Compare ANIP Inventory Turnover Ratio to its Competitors

Financial Statements
Ani Pharmaceuticals Inc's Inventories $ 143 Millions Visit ANIP's Balance sheet
Ani Pharmaceuticals Inc's Cost of Revenues TTM $ 387 Millions Visit ANIP's Income Statement
What are ANIP's Sales? Visit ANIP's Sales by Segment

Other Inventory Turnover Ratios
Ani Pharmaceuticals Inc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ANIP's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ANIP's Competitors
Inventory Turnover Ratio for ANIP's Suppliers
Inventory Turnover Ratio for ANIP's Customers

You may also want to know
ANIP's Sales Growth Rates ANIP's Pe Price to earnings ratio ANIP's Receivables Turnover Ratio ANIP's Stock Quote
ANIP's Net Income Growth Rates ANIP's Ps Price to Sales ratio ANIP's Sales per Employee ANIP's Asset Turnover Ratio
ANIP's Net Margin ANIP's Pb Price to Book ratio ANIP's Financial Strength Ratios ANIP's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Vanda Pharmaceuticals Inc   7.43 $ 13.506  Millions$ 2  Millions
Carlsmed Inc   7.42 $ 13.955  Millions$ 2  Millions
Adaptive Biotechnologies Corporation  7.26 $ 75.254  Millions$ 10  Millions
Lifemd Inc   7.22 $ 22.284  Millions$ 3  Millions
Brightspring Health Services Inc   6.35 $ 4,108.953  Millions$ 647  Millions
Puma Biotechnology Inc   6.29 $ 58.199  Millions$ 9  Millions
Adm Tronics Unlimited Inc   6.05 $ 1.970  Millions$ 0  Millions
Sharps Technology Inc   5.68 $ 2.869  Millions$ 1  Millions
Transmedics Group Inc   5.59 $ 276.120  Millions$ 49  Millions
Cg Oncology Inc   5.47 $ 7.609  Millions$ 1  Millions
Opko Health Inc   5.42 $ 348.206  Millions$ 64  Millions
Charles River Laboratories International inc   5.39 $ 1,761.363  Millions$ 327  Millions
Tactile Systems Technology Inc   5.12 $ 81.349  Millions$ 16  Millions
Integer Holdings Corporation  5.03 $ 1,369.168  Millions$ 272  Millions
Collegium Pharmaceutical Inc   4.99 $ 293.290  Millions$ 59  Millions
Harrow Inc   4.93 $ 73.636  Millions$ 15  Millions
Ufp Technologies Inc   4.93 $ 452.046  Millions$ 92  Millions
Veracyte Inc   4.84 $ 102.741  Millions$ 21  Millions
West Pharmaceutical Services Inc   4.72 $ 2,103.100  Millions$ 445  Millions
Henry Schein Inc   4.68 $ 9,342.000  Millions$ 1,997  Millions
Guardant Health Inc   4.53 $ 413.947  Millions$ 91  Millions
Idexx Laboratories Inc  4.44 $ 1,714.440  Millions$ 386  Millions
Cryoport inc   4.40 $ 98.679  Millions$ 22  Millions
Envista Holdings Corporation  4.37 $ 1,278.500  Millions$ 293  Millions
Adc Therapeutics Sa  4.17 $ 5.806  Millions$ 1  Millions
Scilex Holding Company  4.08 $ 14.867  Millions$ 4  Millions
Medinotec Inc   4.08 $ 4.736  Millions$ 1  Millions
Alpha Teknova Inc   4.08 $ 28.288  Millions$ 7  Millions
3m Company  4.07 $ 15,258.000  Millions$ 3,754  Millions
Electromed Inc   4.02 $ 14.133  Millions$ 4  Millions

Date modified: 2026-09-08T15:22:21+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.